Carnegie Mellon received $28.5 million to develop liver tissue bioprinting, with hopes it can reduce the need for transplants ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the idea of 3D bioprinting.

The university's scientists have received a $28.5 million award from the Advanced Research Projects Agency for Health to develop a transplantable 3D-printed liver patch. The initiative ...

In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms, changes begin to unfold inside the liver. While hepatic fat accumulation ...

There has never been an effective therapy to reduce major adverse liver outcomes in some patients with severe liver scarring — though a recent Cleveland Clinic-led study shows promise. The ...

IF you think you’re overworked, consider your liver. Roughly the size and shape of a football and located in your upper right ...